Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems

Guardado en:
Detalles Bibliográficos
Autores principales: Toibaro, J.J., Losso, M.H.
Formato: JOUR
Materias:
aminotransferase
cytochrome P450 3A4
glycoprotein P
lopinavir plus ritonavir
proteinase inhibitor
rifampicin
ritonavir
ritonavir plus saquinavir
saquinavir
unclassified drug
aminotransferase blood level
clinical trial
drug absorption
drug excretion
drug metabolism
highly active antiretroviral therapy
human
Human immunodeficiency virus infection
letter
liver toxicity
mixed infection
patient compliance
pharmacokinetics
priority journal
side effect
tuberculosis
AIDS-Related Opportunistic Infections
Antibiotics, Antitubercular
Drug Interactions
HIV Protease Inhibitors
Humans
Liver Diseases
Research Design
Rifampin
Tuberculosis
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_02699370_v22_n15_p2046_Toibaro
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires
Descripción
Descripción no disponible.

Ejemplares similares